BillionToOne, Inc.
Nasdaq: BLLN
- 1 clinical trial, 1 active
- Research grants: $448,454
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Biocept Inc
- Raised $2.2 million (2017)
- 1 clinical trial
- Research grants: $100,000
- Founded 2013
Black Diamond Therapeutics, Inc.
Nasdaq: BDTX
- Raised $85 million (2019)
- 3 clinical trials, 2 active
- Founded 2016
Boundless Bio, Inc.
Nasdaq: BOLD
- Raised $100 million (2023)
- 3 clinical trials
- Founded 2018
Brainstorm Cell Therapeutics Inc.
OTC: BCLI
- Raised $11 million (2014)
- 7 clinical trials, 1 active
Bright Minds Biosciences Inc.
Nasdaq: DRUG
- Raised $35 million (2024)
- 3 clinical trials, 2 active
- Founded 2019
Cardiff Oncology, Inc.
Nasdaq: CRDF
- Raised $14 million (2020)
- 7 clinical trials, 1 active
Chimerix Inc
- Raised $35 million (2019)
- 2 clinical trials, 2 active
- Research grants: $599,883
CNS Pharmaceuticals, Inc.
Nasdaq: CNSP
- Raised $23 million (2026)
- 1 clinical trial, 1 active
Dianthus Therapeutics, Inc. /DE/
Nasdaq: DNTH
- Raised $52 million (2018)
- 3 clinical trials
- Founded 2015
GENELUX Corp
Nasdaq: GNLX
- Raised $5.5 million (2023)
- 8 clinical trials, 3 active
Helixbind, Inc.
- Raised $2.9 million (2017)
- 1 clinical trial
- Research grants: $89 million
- Founded 2012
Inovio Pharmaceuticals, Inc.
Nasdaq: INO
- Raised $4 million (2020)
- 41 clinical trials, 1 active
Instil Bio, Inc.
Nasdaq: TIL
- Raised $185 million (2021)
- 4 clinical trials
- Founded 2018
Keros Therapeutics, Inc.
Nasdaq: KROS
- Raised $11 million (2018)
- 3 clinical trials, 1 active
- Founded 2015
Linshom Medical Inc.
- Raised $500,000 (2022)
- 3 clinical trials, 1 active
- Research grants: $7.3 million
Maxcyte, Inc.
Nasdaq: MXCT
- Raised $760,308 (2016)
- 1 clinical trial
- Research grants: $1 million
Microbot Medical Inc.
Nasdaq: MBOT
- Raised $25 million (2025)
- 1 clinical trial
Minerva Neurosciences, Inc.
Nasdaq: NERV
- Raised $1 million (2016)
- 7 clinical trials, 1 active
Myriad Genetics Inc
Nasdaq: MYGN
- Raised $249,390 (2019)
- 12 clinical trials, 4 active
- Research grants: $185,130
Phenomix Sciences, Inc.
- Raised $2.5 million (2025)
- 1 clinical trial, 1 active
- Research grants: $4.3 million
- Founded 2017
Satellos Bioscience Inc.
Nasdaq: MSLE
- Raised $25 million (2025)
- 3 clinical trials, 2 active
- Founded 2021
Stoke Therapeutics, Inc.
Nasdaq: STOK
- Raised $90 million (2018)
- 3 clinical trials, 2 active
- Founded 2014
Tempest Therapeutics, Inc.
Nasdaq: TPST
- Raised $4.1 million (2026)
- 4 clinical trials, 2 active
- Founded 2011
Tyra Biosciences, Inc.
Nasdaq: TYRA
- Raised $200 million (2024)
- 7 clinical trials, 7 active
Werewolf Therapeutics, Inc.
Nasdaq: HOWL
- Raised $72 million (2021)
- 3 clinical trials, 1 active
- Founded 2017
Zevra Therapeutics, Inc.
Nasdaq: ZVRA
- Raised $39 million (2021)
- 3 clinical trials
- Founded 2014
Insightec Ltd
- Raised $150 million (2024)
- 84 clinical trials, 23 active
- FDA-cleared or approved devices
Acutus Medical, Inc.
- Raised $137 million (2019)
- 14 clinical trials
- Founded 2011
Inari Medical, Inc.
- Raised $27 million (2018)
- 14 clinical trials, 7 active
- Founded 2011
IPI Legacy Liquidation Co
- Raised $7.5 million (2021)
- Research grants: $4.3 million
- Founded 2008
Oncosynergy, Inc.
- Raised $6.6 million (2026)
- 1 clinical trial
- Research grants: $2 million
Tiziana Life Sciences Ltd
Nasdaq: TLSA
- 14 clinical trials, 4 active
- Founded 1998
Bio-Path Holdings, Inc.
OTC: BPTH
- Raised $4 million (2024)
- 6 clinical trials, 4 active
Cardiodx Inc
- Raised $18 million (2017)
- 13 clinical trials
- Research grants: $205,804
Entera Bio Ltd.
Nasdaq: ENTX
- Raised $6.6 million (2024)
- 6 clinical trials
Evolus, Inc.
Nasdaq: EOLS
- Raised $40 million (2020)
- 6 clinical trials
Fisher Wallace Laboratories, Inc.
- Private funding (2025)
- 2 clinical trials
- FDA-cleared or approved devices
Intelligent Bio Solutions Inc.
Nasdaq: INBS
- Raised $10 million (2026)
- 6 clinical trials, 3 active
NeuroSense Therapeutics Ltd.
Nasdaq: NRSN
- Raised $5 million (2024)
- 6 clinical trials
Solid Biosciences Inc.
Nasdaq: SLDB
- Raised $9.2 million (2022)
- 6 clinical trials, 5 active
Bioincept LLC
- Raised $3.1 million (2020)
- 2 clinical trials
- Research grants: $4.9 million
Aimmune Therapeutics, Inc.
- Raised $98 million (2018)
- 13 clinical trials, 1 active
- Founded 2011
Ironwood Pharmaceuticals Inc
Nasdaq: IRWD
- Raised $150 million (2016)
- 39 clinical trials
Kodiak Sciences Inc.
Nasdaq: KOD
- Raised $34 million (2016)
- 12 clinical trials, 4 active
- Founded 2009
Smith & Nephew, Inc.
- 136 clinical trials, 22 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Presage Biosciences, Inc.
- Raised $8 million (2013)
- 10 clinical trials, 1 active
- Research grants: $7.7 million
- Founded 2008
Natera, Inc.
Nasdaq: NTRA
- 39 clinical trials, 17 active
- FDA-cleared or approved devices
Acurx Pharmaceuticals, Inc.
Nasdaq: ACXP
- Raised $4.6 million (2026)
- 2 clinical trials, 1 active
- Founded 2017
Amplified Sciences, Inc.
- Raised $3 million (2026)
- 1 clinical trial, 1 active
- Research grants: $909,770
- Founded 2016
Published company profiles only; counts update daily. Data licences